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Abstract
Ethylene glycol toxicity can have various clinical presentations 
with different organ system involvements. These presentations are 
independent of the level of toxicity. We describe a 31 years old male 
who presented with ethylene glycol toxicity manifesting as anuric 
renal failure who subsequently developed neurological sequela of 
its toxicity. Ethylene glycol is known to be metabolized to various 
metabolites and is ultimately converted to oxalate which results in 
crystal deposition the renal parenchyma causing renal failure. Oxa-
late deposition can occur in various organs including the nervous 
system as seen in our patient. The majority of patients do not recov-
er from severe oxalosis despite the supportive care of hemodialysis 
in removing the parent compounds. Despite severe oxalosis, our 
patient was fortunate enough to be left with minimal neurological 
sequelae, and eventually was able to cease hemodialysis treatments.
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Introduction
Ethylene glycol intoxication can present in various ways. 
Identification  and  treatment  of  such  intoxication  is  very 
important in order to avoid future complications. The me-
tabolites of ethylene glycol are toxic and can result in multi-
organ system damage. It is therefore important to understand 
the metabolism of the chemical and the pathophysiologic 
mechanisms  by  which  it  inflicts  damage.  Understanding 
these concepts will help one to readily identify the toxin, 
treat the patients, and manage the complications.
Case Report
A 31 years old male with a past medical history of Hepatitis 
C, depression, and prior suicide attempts was brought to the 
emergency department (ED) by his family. Three days prior 
to admission he had ingested about 10 - 20 cc of antifreeze 
(ethylene glycol), 100 mg of Vistaril and 200 mg of Doxepi-
nel in a suicide attempt. He had no contributory past surgical 
history or family history. He admitted to addiction to cocaine 
and heroin and was discharged from a detoxification facility 
1 week prior to admission. He stated that he had no recollec-
tion of events that transpired between the ingestion of eth-
ylene glycol and his presentation to the ED. He was found 
unresponsive at home and brought into the hospital and was 
awake and alert on presentation to the hospital.
In the ED the patient had a blood pressure of 103/59, 
heart rate of 92, respiratory rate of 18 and temperature of 
100 degrees Fahrenheit. The patient was alert and oriented 
to self, location and time. The heart rate was regular with no 
murmurs, rubs or gallops, and the lungs were clear to aus-
cultation, with no rales, rhonchi or wheezes. The abdomen 
was soft, non tender, not distended with no organomegaly, 
and bowel sounds were present in all four quadrants. The 
extremities had no edema, and had acceptable pulses were 
present. He was able to follow commands and did not have 
any short term memory defecit. Cranial nerves were intact, 
strength was 5/5 in all extremities, sensorium was intact to 
pinprick and light touch, and deep tendon reflex responses 
appropriate.
The patient was noted to have transaminitis which was 
attributed to Hepatitis C, and was also found to be in a high 
anion gap metabolic acidosis (17 mEq/L) with acute kidney 
injury (Creatinine 12.55 mg/dL), with total urine output of 
5 mL during the first eight hours. Osmolar gap on presenta-
tion was within the normal range. He was admitted to the 
intensive care unit for treatment and observation and was 
started on intravenous normal saline, and oral pyridoxine 
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and thiamine. An admission urinalysis had shown 3+ pro-
tein, 0 - 3 red blood cells, 6 - 12 white blood cells (per high 
power field), moderate bacteria, no casts, and no crystals. 
The fractional excretion of sodium was calculated to be 
approximately 20%. Renal sonogram revealed a right and 
left kidney of 13.4 and 14.2 cm respectively, with increased 
echotexture, and no hydronephrosis, masses or calculi. Se-
rologic workup for causes of renal failure was found to be 
negative (C3, C4, antinuclear antibody, rheumatoid factor, 
anti-neutrophil cytoplasmic antibody and HIV). The cause of 
kidney injury was presumed to be due to oxalosis from the 
ethylene glycol ingestion. He continued to be anuric despite 
volume repletion and his electrolytes worsened, so he was 
started on hemodialysis. Renal core biopsy was obtained, 
and showed a significant amount of tubular injury caused by 
oxalate crystal deposition (Fig.1).
Five days after admission the patient began complaining 
of tinnitus in his right ear as well as vertigo and acute ves-
tibular neuritis was suspected. MRI of the brain along with 
a lumbar puncture was performed. He was found to have 
sterile meningitis. He was started on steroids and meclizine 
without significant improvement in symptoms.
Twelve days after admission the patient began to com-
plain of hearing loss in his right ear and developed left fa-
cial droop (distribution of V2 and V3) and right eye ptosis. 
His mental status began to worsen as he became increas-
ingly lethargic, and he developed a fever and leukocytosis. 
He refused a repeat LP and empiric antibiotics were started. 
He began to have difficulty swallowing which was severe 
enough to require that all feeding be via a nasogastric tube. 
By this time, his hearing loss was profound, and it became 
difficult to communicate with him. Subsequently he began to 
have progressive shortness of breath and required intubation 
and mechanical ventilation. He failed to tolerate the removal 
of ventilatory support, and underwent tracheostomy and per-
cutaneous endoscopic gastrostomy tube placement.
Three weeks after intubation, the patient began to regain 
consciousness and had progressive improvement of his men-
tal status. Pt was successfully weaned off of the ventilator at 
this point. He began to open his eyes, then began to answer 
questions appropriately and progressively improved until he 
returned to the baseline mental status that he displayed upon 
arrival to the ED.  He was discharged to an inpatient rehabili-
tation center where his condition continued to improve and 
he was able to fully ambulate after several weeks. He contin-
ued to require hemodialysis, but began to produce urine. Re-
peat microanalysis of his urine failed to indicate active sedi-
ment and his renal function did not improve. The patient was 
finally discharged home with outpatient hemodialysis three 
times a week. Approximately 5 months later, his renal func-
tion began to improve and hemodialysis was dicontinued. A 
partial facial palsy remains, as well as a mild hearing deficit.
 
Discussion
  
Ethylene glycol, methanol, and isopropyl alcohol are toxic 
alcohols that are available in both commercial and household 
products and have been used in suicide attempts [1]. Meth-
anol and ethylene glycol toxicity can be fatal and prompt 
intervention is warranted. Ethylene Glycol is a nonvolatile 
liquid that is colorless and odorless. It is found commonly in 
antifreeze, coolants, cleansers, and windshield de-icers [2]. 
Reporting of exposures to ethylene glycol is not mandatory 
so there may be an underestimation in national statistics. In 
2007 the US poison centers received reports of 5731 cases 
that may have been exposed [3].
Historically, ethylene glycol toxicity has been divided 
into three stages and a proposed fourth stage, which will be 
discussed separately [4]. The first stage involves central ner-
vous system depression and GI irritation. The initial symp-
toms may mimic those of ethanol intoxication but the pa-
tients don’t usually have the smell of alcohol on their breath 
unless there is co-ingestion. Gastritis may result from direct 
irritation of the gastrointestinal tract [4]. This stage may last 
from 30 minutes to 12 hours. The second stage of ethylene 
glycol intoxication involves cardiopulmonary collapse and 
occurs at about 12 to 24 hours after ingestion. The symptoms 
of this stage are tachypnea, hypotension, and congestive 
heart failure with pulmonary edema leading to acute respira-
tory distress syndrome [4]. Ethylene glycol is metabolized 
to its toxic compounds and anion gap metabolic acidosis oc-
curs in this second stage [5]. The third stage of intoxication 
involves the kidneys and is termed the renal stage [1]. The 
metabolites of ethylene glycol are deposited in the kidney 
and the patient may develop an oliguric renal failure sec-
ondary to calcium oxalate crystal deposition [6]. The renal 
stage can last for months, as seen in our patient. The fourth 
stage of intoxication involves the neurologic complications 
that occur days to weeks after initial intoxication and may 
involve cranial nerves [7].
The metabolism of ethylene glycol is of vital importance 
Figure 1. Renal core biopsy showed a significant amount of tu-
bular injury caused by oxalate crystal deposition.
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in understanding the serologic and clinical presentation (Fig. 
2). Ehtylene glycol is metabolized by alcohol dehydroge-
nase (ADH) in the liver to which glycoaldehyde is in turn 
metabolized by aldehyde deyhdrogenase to glycolic acid [3, 
6]. Glycolic acid is metabolized by glycolate oxidase to gly-
oxylic acid which can now take one of several pathways. It 
can be converted by alanine-glyoxylate aminotransferase to 
glycine, which is a step that may be enhanced by adminis-
tration of pyridoxine or be converted into formic acid and 
into alpha hydroxyl beta ketoadipate, the latter conversion 
enhanced by thiamine [1]. The fourth and most important 
pathway that glyoxylic acid can take is conversion to oxalic 
acid via the enzyme lactate dehydrogenase. Oxalic acid is 
excreted in the urine but when it binds calcium, it becomes 
calcium oxalate, which is the compound that forms oxalate 
crystals and gets deposited in the kidney causing kidney fail-
ure [1, 6]. It is important to note here that hypocalcemia is 
among the electrolyte abnormalities that may develop as a 
result of this binding.
The recognition of ethylene glycol intoxication can be 
challenging. As discussed previously the initial presentation 
of altered mental status, nausea, and vomiting may be non-
specific and vague. It is therefore of critical importance to 
conduct an appropriate history from family or friends and 
a proper investigation for possible ingestion. Although our 
patient was awake when he presented to the ED, he was 
unable to recall the events that transpired from the time of 
consumption until the time of presentation. Direct ethylene 
glycol measurement is not available in many hospitals and 
the results do take some time to come back. Calcium oxalate 
crystalluria can be found in up to 50% of patients with eth-
ylene glycol poisoning [1, 8]. Crystals have been document-
ed in urine for over a month after exposure to even modest 
amounts of ethylene glycol [8]. Another diagnostic clue is 
urine that is positive under a Wood’s lamp since fluorescein 
is added to antifreeze [1]. This is just a clue and a negative 
test should not be criteria for ruling out intoxication [1]. If 
the patient is anuric on presentation from kidney failure, it 
has been suggested to perform bladder irrigation with 100 
mL of saline. The solution can then be prepared and exam-
ined for calcium oxalate crystals [9]. There have been cases 
of death reported with extremely high levels of ethylene gly-
col but without the crystalluria or the metabolites [10]. The 
patient discussed in this case had a tremendous amount of 
oxalate on kidney biopsy, but did not have any crystals in 
the urine.
The acid base presentation of ethylene glycol intoxica-
tion can vary depending on time after exposure [11]. The 
classic presentation is an osmolal gap which is followed by 
an anion gap metabolic acidosis. Ethylene glycol itself con-
tributes to the osmolal gap, but this gap closes as ethylene 
glycol is metabolized [1]. The metabolites of ethylene glycol 
are what contribute to the anion gap. Out patient presented 
with an anion gap metabolic acidosis without an osmolal 
Figure 2. The metabolism of ethylene glycol.
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gap. This is likely due to metabolism of the parent alcohol, 
which contributes to the osmolal gap. Glycolic acid is the 
metabolite that contributes to the anion gap. This is impor-
tant because the patient may present with osmolal gap alone 
initially, an osmolal and an anion gap metabolic acidosis, or 
with an anion gap metabolic acidosis alone [12]. There have 
also been a number of cases reviewed in the literature where 
patients present with non-anion gap metabolic acidosis [5].     
In a number of these patients, no reason was identified for 
losses that would offset the anion gap. Other causes to con-
sider of an anion gap metabolic acidosis include ketones, 
lactate, and organic acids from renal failure.
Criteria for initiating therapy for ethylene glycol include 
a plasma concentration of ethylene glycol of greater than 20 
milligrams per deciliter, or a documented ingestion history 
with an osmolal gap of greater than 10 milliosmoles per liter, 
or suspected ingestion with three of the following param-
eters, arterial pH of less than 7.3, carbon dioxide of less than 
20 mmoL per liter, an osmolal gap greater than 10 millios-
moles per liter or oxalate crystals in the urine [3].
Treatment for ethylene glycol intoxication involves the 
use of fomepizole (4-methylpyrazole) and hemodialysis. 
Since the metabolites of ethylene glycol are toxic substanc-
es, the enzyme alcohol dehydrogenase, which plays a role in 
this conversion, is the target of this drug. Intravenous ethanol 
has an affinity for alcohol dehydragenase that is 100 times 
more than ethylene glycol [1]. This relationship is impor-
tant because patients who have co-ingestion of both ethylene 
glycol and ethanol will have a delayed presentation of ethyl-
ene glycol toxicity since it will take longer to metabolize the 
ethylene glycol. There are however side effects that come 
along with ethanol infusion including mental status changes, 
pancreatitis and hypoglycemia [1]. Fomepizole is a competi-
tive inhibitor which reversible binds to alcohol dehydroge-
nase. Fomepizole does not have the side effect profile that 
ethanol has and its pharmacokinetics are more predictable 
[3]. Hemodialysis is used to remove the parent compound, 
ethylene glycol. Other agents that are given are pyridoxine 
and thiamine since they both help shift metabolism of glyox-
ylic acid to glycine and alpha hydroxyl beta ketoadipate, re-
spectively [1]. The result is shifting the pathway away from 
formation of oxalate acid which when coupled with calcium 
is toxic to the kidneys and central nervous system.
As stated previously, calcium oxalate deposition in the 
kidneys causes toxicity and renal failure. Calcium oxalate 
monohydrate (COM) is the toxic agent [6]. COM is toxic to 
the proximal tubule, where it has been shown get internal-
ized which results in cell death (acute tubular necrosis) [6].   
There are several factors that can bind to COM and prevent 
them from binding membrane receptors. COM has a posi-
tively charged surface which reacts with several negatively 
charged sites on the cell membrane [6]. Polyanions that 
interact with the cell surface of COM crystals and inhibit 
membrane uptake include the glycoprotein osteopontin, gly-
cosaminoglycans, and citrate [6]. COM crystals can also ag-
gregate in the lumen of the tubule and this is inhibited by se-
cretion of Tamm-Horsefall protein [6]. This differs from the 
pathologic mechanism of calcium oxalate nephrolithiasis in 
that kidney stones attach to Randall’s plaque in the papillary 
interstitium. Cell damage results from varying mechanism, 
not all fully understood, but involving mitochondrial dys-
function, membrane damage, and free radical generation [6]. 
When examined under polarized light, the crystals appear 
“mussel-shaped” [13]. Our patient had a tremendous amount 
of oxalate on kidney biopsy and required hemodialysis for 
approximately 5 months, after which he came off.
Ethylene glycol intoxication also has central nervous 
system manifestations which are described to be a stage in 
the intoxication cascade. A common finding involves central 
edema with basal ganglia and brainstem involvement [13]. 
The cortical gray matter is spared. Increased signal intensi-
ties can frequently be seen on MRI images of the basal gan-
glia [13, 14]. Calcium oxalate crystals have also been found 
to be deposited in the walls of central nervous system blood 
vessels [15]. Autopsy findings include birefringent crystals 
in vessel walls and perivascular edema with polymorpho-
nuclear leukocytes [15]. These findings are important be-
cause development of medications that inhibit the uptake 
of calcium oxalate monohydrate crystals may minimize or 
even prevent toxicity. Cranial nerve involvement is a com-
mon finding in the neurologic sequelae. The seventh and 
eight cranial nerves are commonly involved and it has been 
suggested to call this phase “facial-auditory nerve oxalosis” 
[16, 17]. There have also been documented cases of deficits 
in other cranial nerves such as VI, IX, and X which result 
in visual disturbances and dysphagia [18, 19]. Our patient 
also displayed a neurological sequel which involved several 
cranial nerves similar to the case reports described. Ethylene 
glycol intoxication can also result in a neuropsychological 
sequelae [20]. Patients may have a decline in cognitive func-
tion that persists months after intoxication [20]. Patients may 
also have meningismus. Deposition of calcium oxalate in the 
meninges may result in a sterile meningitis [21]. A lumbar 
puncture performed on our patient also revealed a sterile 
meningitis. Cerebrospinal fluid may show elevated protein 
or polymorphonuclear pleocytosis [21].
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